Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jonathan Mcneill

COO, President at Crescent Biopharma, Inc. (CBIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $447K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 18SEC CBIOCrescent Biopharma, Inc. Sell Plan 731138,427 held (−1%) $17.90 $13K -33.9%
Sep 18SEC CBIOCrescent Biopharma, Inc. Sell Plan 3,839134,588 held (−3%) $16.71 $64K -29.1%
Jun 23SEC CBIOCrescent Biopharma, Inc. Sell Plan 20,549139,158 held (−13%) $17.99 $370K -34.2%
  • Sell

    COO, President Jonathan Mcneill sold $13K of CBIO at $17.90 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO, President Jonathan Mcneill sold $64K of CBIO at $16.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO, President Jonathan Mcneill sold $370K of CBIO at $17.99 — pre-scheduled 10b5-1 plan sale.